(Q33753095)

29 July 2017

title

Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: results of a pilot study (English)

1 reference

29 July 2017

1 reference

1 reference

Prosnitz RG

1

1 reference

29 July 2017

Schneider L

2

1 reference

29 July 2017

Manola J

3

1 reference

29 July 2017

Rocha S

4

1 reference

29 July 2017

Loffredo M

5

1 reference

29 July 2017

Lopes L

6

1 reference

29 July 2017

D'Amico AV

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

International Journal of Radiation Oncology Biology Physics

29 July 2017

published in

1 reference

29 July 2017

volume

45

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

563-566

1 reference

Conformal radiation in prostate cancer: reduced morbidity with hope of increased local control

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Molecular cloning and sequencing of a cDNA encoding a human alpha 1A adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

Localization of the alpha 1A-adrenoceptor in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900246-1

7 January 2021

10.1016/S0360-3016(99)00246-1

Identifiers

DOI

1 reference

29 July 2017

1 reference